British Airways Pensions Investment Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$11.7M Hold
166,544
0.46% 70
2021
Q1
$11.7M Buy
166,544
+22,254
+15% +$1.59M 0.46% 70
2020
Q4
$8.63M Sell
144,290
-9,300
-6% -$545K 0.33% 87
2020
Q3
$9.23M Buy
+153,590
New +$8.92M 0.37% 78

Other funds holding PCRX

British Airways Pensions Investment Management's PCRX Position: Q2 2021 in Review

British Airways Pensions Investment Management held its Pacira BioSciences (PCRX) position steady in Q2 2021 at 166,544 shares worth $11.7M. The position accounts for 0.46% of the portfolio, ranked #70.

British Airways Pensions Investment Management first reported a position in PCRX in Q3 2020 and has held it in 4 quarters since. 262 funds tracked by Wall St. Rank hold PCRX as of Q2 2021.

  • British Airways Pensions Investment Management held 166,544 shares of Pacira BioSciences worth $11.7M as of Q2 2021.
  • British Airways Pensions Investment Management left its Pacira BioSciences share count unchanged in Q2 2021.
  • Pacira BioSciences made up 0.46% of British Airways Pensions Investment Management's portfolio in Q2 2021, its #70 holding.
  • British Airways Pensions Investment Management first reported a position in Pacira BioSciences in Q3 2020 and has held it in 4 quarters since.
  • 262 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2021.

Based on British Airways Pensions Investment Management's 13F filing for Q2 2021, filed 5 Aug 2021.